Fludarabine
The global Fludarabine market is segmented by company, region (country), by Type, and by Applicat ... Read More
Global Bicalutamide Sales Market Report 2024
1 Bicalutamide Market Overview
1.1 Bicalutamide Product Scope
1.2 Bicalutamide Segment by Type
1.2.1 Global Bicalutamide Sales by Type (2016 & 2021 & 2027)
1.2.2 Tablets
1.2.3 Capsule
1.3 Bicalutamide Segment by Application
1.3.1 Global Bicalutamide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Bicalutamide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bicalutamide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bicalutamide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bicalutamide Price Trends (2016-2027)
2 Bicalutamide Estimates and Forecasts by Region
2.1 Global Bicalutamide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bicalutamide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bicalutamide Sales Market Share by Region (2016-2021)
2.2.2 Global Bicalutamide Revenue Market Share by Region (2016-2021)
2.3 Global Bicalutamide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bicalutamide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bicalutamide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bicalutamide Estimates and Projections (2016-2027)
2.4.2 Europe Bicalutamide Estimates and Projections (2016-2027)
2.4.3 China Bicalutamide Estimates and Projections (2016-2027)
2.4.4 Japan Bicalutamide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bicalutamide Estimates and Projections (2016-2027)
2.4.6 India Bicalutamide Estimates and Projections (2016-2027)
3 Global Bicalutamide Competition Landscape by Players
3.1 Global Top Bicalutamide Players by Sales (2016-2021)
3.2 Global Top Bicalutamide Players by Revenue (2016-2021)
3.3 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bicalutamide as of 2020)
3.4 Global Bicalutamide Average Price by Company (2016-2021)
3.5 Manufacturers Bicalutamide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Bicalutamide Market Size by Type
4.1 Global Bicalutamide Historic Market Review by Type (2016-2021)
4.1.1 Global Bicalutamide Sales Market Share by Type (2016-2021)
4.1.2 Global Bicalutamide Revenue Market Share by Type (2016-2021)
4.1.3 Global Bicalutamide Price by Type (2016-2021)
4.2 Global Bicalutamide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bicalutamide Sales Forecast by Type (2022-2027)
4.2.2 Global Bicalutamide Revenue Forecast by Type (2022-2027)
4.2.3 Global Bicalutamide Price Forecast by Type (2022-2027)
5 Global Bicalutamide Market Size by Application
5.1 Global Bicalutamide Historic Market Review by Application (2016-2021)
5.1.1 Global Bicalutamide Sales Market Share by Application (2016-2021)
5.1.2 Global Bicalutamide Revenue Market Share by Application (2016-2021)
5.1.3 Global Bicalutamide Price by Application (2016-2021)
5.2 Global Bicalutamide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bicalutamide Sales Forecast by Application (2022-2027)
5.2.2 Global Bicalutamide Revenue Forecast by Application (2022-2027)
5.2.3 Global Bicalutamide Price Forecast by Application (2022-2027)
6 North America Bicalutamide Market Facts & Figures
6.1 North America Bicalutamide Sales by Company
6.1.1 North America Bicalutamide Sales by Company (2016-2021)
6.1.2 North America Bicalutamide Revenue by Company (2016-2021)
6.2 North America Bicalutamide Sales Breakdown by Type
6.2.1 North America Bicalutamide Sales Breakdown by Type (2016-2021)
6.2.2 North America Bicalutamide Sales Breakdown by Type (2022-2027)
6.3 North America Bicalutamide Sales Breakdown by Application
6.3.1 North America Bicalutamide Sales Breakdown by Application (2016-2021)
6.3.2 North America Bicalutamide Sales Breakdown by Application (2022-2027)
7 Europe Bicalutamide Market Facts & Figures
7.1 Europe Bicalutamide Sales by Company
7.1.1 Europe Bicalutamide Sales by Company (2016-2021)
7.1.2 Europe Bicalutamide Revenue by Company (2016-2021)
7.2 Europe Bicalutamide Sales Breakdown by Type
7.2.1 Europe Bicalutamide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bicalutamide Sales Breakdown by Type (2022-2027)
7.3 Europe Bicalutamide Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Bicalutamide Market Facts & Figures
8.1 China Bicalutamide Sales by Company
8.1.1 China Bicalutamide Sales by Company (2016-2021)
8.1.2 China Bicalutamide Revenue by Company (2016-2021)
8.2 China Bicalutamide Sales Breakdown by Type
8.2.1 China Bicalutamide Sales Breakdown by Type (2016-2021)
8.2.2 China Bicalutamide Sales Breakdown by Type (2022-2027)
8.3 China Bicalutamide Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Bicalutamide Market Facts & Figures
9.1 Japan Bicalutamide Sales by Company
9.1.1 Japan Bicalutamide Sales by Company (2016-2021)
9.1.2 Japan Bicalutamide Revenue by Company (2016-2021)
9.2 Japan Bicalutamide Sales Breakdown by Type
9.2.1 Japan Bicalutamide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bicalutamide Sales Breakdown by Type (2022-2027)
9.3 Japan Bicalutamide Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Bicalutamide Market Facts & Figures
10.1 Southeast Asia Bicalutamide Sales by Company
10.1.1 Southeast Asia Bicalutamide Sales by Company (2016-2021)
10.1.2 Southeast Asia Bicalutamide Revenue by Company (2016-2021)
10.2 Southeast Asia Bicalutamide Sales Breakdown by Type
10.2.1 Southeast Asia Bicalutamide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bicalutamide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bicalutamide Sales Breakdown by Application
10.3.1 Southeast Asia M Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Pcs Sales Breakdown by Application (2022-2027)
11 India Bicalutamide Market Facts & Figures
11.1 India Bicalutamide Sales by Company
11.1.1 India Bicalutamide Sales by Company (2016-2021)
11.1.2 India Bicalutamide Revenue by Company (2016-2021)
11.2 India Bicalutamide Sales Breakdown by Type
11.2.1 India Bicalutamide Sales Breakdown by Type (2016-2021)
11.2.2 India Bicalutamide Sales Breakdown by Type (2022-2027)
11.3 India Bicalutamide Sales Breakdown by Application
11.3.1 India Bicalutamide Sales Breakdown by Application (2016-2021)
11.3.2 India Bicalutamide Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Bicalutamide Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Bicalutamide Products Offered
12.1.5 AstraZeneca Recent Development
12.2 CORDEN PHARMA GMBH
12.2.1 CORDEN PHARMA GMBH Corporation Information
12.2.2 CORDEN PHARMA GMBH Business Overview
12.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CORDEN PHARMA GMBH Bicalutamide Products Offered
12.2.5 CORDEN PHARMA GMBH Recent Development
12.3 Zeneca GmbH
12.3.1 Zeneca GmbH Corporation Information
12.3.2 Zeneca GmbH Business Overview
12.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zeneca GmbH Bicalutamide Products Offered
12.3.5 Zeneca GmbH Recent Development
12.4 Actavis Pharma
12.4.1 Actavis Pharma Corporation Information
12.4.2 Actavis Pharma Business Overview
12.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Actavis Pharma Bicalutamide Products Offered
12.4.5 Actavis Pharma Recent Development
12.5 Sivem Pharmaceuticals
12.5.1 Sivem Pharmaceuticals Corporation Information
12.5.2 Sivem Pharmaceuticals Business Overview
12.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sivem Pharmaceuticals Bicalutamide Products Offered
12.5.5 Sivem Pharmaceuticals Recent Development
12.6 Sorres Pharma
12.6.1 Sorres Pharma Corporation Information
12.6.2 Sorres Pharma Business Overview
12.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sorres Pharma Bicalutamide Products Offered
12.6.5 Sorres Pharma Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Corporation Information
12.7.2 Fresenius Kabi Business Overview
12.7.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Fresenius Kabi Bicalutamide Products Offered
12.7.5 Fresenius Kabi Recent Development
12.8 ANI Pharmaceuticals
12.8.1 ANI Pharmaceuticals Corporation Information
12.8.2 ANI Pharmaceuticals Business Overview
12.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 ANI Pharmaceuticals Bicalutamide Products Offered
12.8.5 ANI Pharmaceuticals Recent Development
12.9 Accel Pharma
12.9.1 Accel Pharma Corporation Information
12.9.2 Accel Pharma Business Overview
12.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Accel Pharma Bicalutamide Products Offered
12.9.5 Accel Pharma Recent Development
12.10 Apotex Corporation
12.10.1 Apotex Corporation Corporation Information
12.10.2 Apotex Corporation Business Overview
12.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Apotex Corporation Bicalutamide Products Offered
12.10.5 Apotex Corporation Recent Development
12.11 Shanghai Fudan Fuhua Pharmaceutical
12.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
12.11.2 Shanghai Fudan Fuhua Pharmaceutical Business Overview
12.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Products Offered
12.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Development
12.12 Shanghai Zhaohui Pharmaceutical
12.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
12.12.2 Shanghai Zhaohui Pharmaceutical Business Overview
12.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Products Offered
12.12.5 Shanghai Zhaohui Pharmaceutical Recent Development
12.13 Zhejiang Haizheng Pharmaceutical
12.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
12.13.2 Zhejiang Haizheng Pharmaceutical Business Overview
12.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Products Offered
12.13.5 Zhejiang Haizheng Pharmaceutical Recent Development
12.14 Shanxi Zhendong Pharmaceutical
12.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
12.14.2 Shanxi Zhendong Pharmaceutical Business Overview
12.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Products Offered
12.14.5 Shanxi Zhendong Pharmaceutical Recent Development
13 Bicalutamide Manufacturing Cost Analysis
13.1 Bicalutamide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bicalutamide
13.4 Bicalutamide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bicalutamide Distributors List
14.3 Bicalutamide Customers
15 Market Dynamics
15.1 Bicalutamide Market Trends
15.2 Bicalutamide Drivers
15.3 Bicalutamide Market Challenges
15.4 Bicalutamide Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Bicalutamide Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bicalutamide Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bicalutamide Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bicalutamide Sales (M Pcs) by Region (2016-2021)
Table 5. Global Bicalutamide Sales Market Share by Region (2016-2021)
Table 6. Global Bicalutamide Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bicalutamide Revenue Share by Region (2016-2021)
Table 8. Global Bicalutamide Sales (M Pcs) Forecast by Region (2022-2027)
Table 9. Global Bicalutamide Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bicalutamide Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bicalutamide Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bicalutamide Sales (M Pcs) of Key Companies (2016-2021)
Table 13. Global Bicalutamide Sales Share by Company (2016-2021)
Table 14. Global Bicalutamide Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bicalutamide Revenue Share by Company (2016-2021)
Table 16. Global Bicalutamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bicalutamide as of 2020)
Table 17. Global Bicalutamide Average Price (US$/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Bicalutamide Manufacturing Sites and Area Served
Table 19. Manufacturers Bicalutamide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bicalutamide Sales (M Pcs) by Type (2016-2021)
Table 22. Global Bicalutamide Sales Share by Type (2016-2021)
Table 23. Global Bicalutamide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bicalutamide Price (US$/Pcs) by Type (2016-2021)
Table 25. Global Bicalutamide Sales Share by Type (2022-2027)
Table 26. Global Bicalutamide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bicalutamide Revenue Share by Type (2022-2027)
Table 28. Global Bicalutamide Price (US$/Pcs) by Type (2022-2027)
Table 29. Global Bicalutamide Sales (M Pcs) by Application (2016-2021)
Table 30. Global Bicalutamide Sales Share by Application (2016-2021)
Table 31. Global Bicalutamide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bicalutamide Price (US$/Pcs) by Application (2016-2021)
Table 33. Global Bicalutamide Sales (M Pcs) by Application (2022-2027)
Table 34. Global Bicalutamide Sales Share by Application (2022-2027)
Table 35. Global Bicalutamide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bicalutamide Revenue Share by Application (2022-2027)
Table 37. Global Bicalutamide Price (US$/Pcs) by Application (2022-2027)
Table 38. North America Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 39. North America Bicalutamide Sales Market Share by Company (2016-2021)
Table 40. North America Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bicalutamide Revenue Market Share by Company (2016-2021)
Table 42. North America Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 43. North America Bicalutamide Sales Market Share by Type (2016-2021)
Table 44. North America Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 45. North America Bicalutamide Sales Market Share by Type (2022-2027)
Table 46. North America Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 47. North America Bicalutamide Sales Market Share by Application (2016-2021)
Table 48. North America Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 49. North America Bicalutamide Sales Market Share by Application (2022-2027)
Table 50. Europe Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 51. Europe Bicalutamide Sales Market Share by Company (2016-2021)
Table 52. Europe Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bicalutamide Revenue Market Share by Company (2016-2021)
Table 54. Europe Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 55. Europe Bicalutamide Sales Market Share by Type (2016-2021)
Table 56. Europe Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 57. Europe Bicalutamide Sales Market Share by Type (2022-2027)
Table 58. Europe Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 59. Europe Bicalutamide Sales Market Share by Application (2016-2021)
Table 60. Europe Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 61. Europe Bicalutamide Sales Market Share by Application (2022-2027)
Table 62. China Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 63. China Bicalutamide Sales Market Share by Company (2016-2021)
Table 64. China Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bicalutamide Revenue Market Share by Company (2016-2021)
Table 66. China Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 67. China Bicalutamide Sales Market Share by Type (2016-2021)
Table 68. China Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 69. China Bicalutamide Sales Market Share by Type (2022-2027)
Table 70. China Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 71. China Bicalutamide Sales Market Share by Application (2016-2021)
Table 72. China Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 73. China Bicalutamide Sales Market Share by Application (2022-2027)
Table 74. Japan Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 75. Japan Bicalutamide Sales Market Share by Company (2016-2021)
Table 76. Japan Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bicalutamide Revenue Market Share by Company (2016-2021)
Table 78. Japan Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 79. Japan Bicalutamide Sales Market Share by Type (2016-2021)
Table 80. Japan Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 81. Japan Bicalutamide Sales Market Share by Type (2022-2027)
Table 82. Japan Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 83. Japan Bicalutamide Sales Market Share by Application (2016-2021)
Table 84. Japan Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 85. Japan Bicalutamide Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 87. Southeast Asia Bicalutamide Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bicalutamide Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 91. Southeast Asia Bicalutamide Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 93. Southeast Asia Bicalutamide Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 95. Southeast Asia Bicalutamide Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 97. Southeast Asia Bicalutamide Sales Market Share by Application (2022-2027)
Table 98. India Bicalutamide Sales (M Pcs) by Company (2016-2021)
Table 99. India Bicalutamide Sales Market Share by Company (2016-2021)
Table 100. India Bicalutamide Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bicalutamide Revenue Market Share by Company (2016-2021)
Table 102. India Bicalutamide Sales by Type (2016-2021) & (M Pcs)
Table 103. India Bicalutamide Sales Market Share by Type (2016-2021)
Table 104. India Bicalutamide Sales by Type (2022-2027) & (M Pcs)
Table 105. India Bicalutamide Sales Market Share by Type (2022-2027)
Table 106. India Bicalutamide Sales by Application (2016-2021) & (M Pcs)
Table 107. India Bicalutamide Sales Market Share by Application (2016-2021)
Table 108. India Bicalutamide Sales by Application (2022-2027) & (M Pcs)
Table 109. India Bicalutamide Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 113. AstraZeneca Bicalutamide Product
Table 114. AstraZeneca Recent Development
Table 115. CORDEN PHARMA GMBH Corporation Information
Table 116. CORDEN PHARMA GMBH Description and Business Overview
Table 117. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 118. CORDEN PHARMA GMBH Bicalutamide Product
Table 119. CORDEN PHARMA GMBH Recent Development
Table 120. Zeneca GmbH Corporation Information
Table 121. Zeneca GmbH Description and Business Overview
Table 122. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 123. Zeneca GmbH Bicalutamide Product
Table 124. Zeneca GmbH Recent Development
Table 125. Actavis Pharma Corporation Information
Table 126. Actavis Pharma Description and Business Overview
Table 127. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 128. Actavis Pharma Bicalutamide Product
Table 129. Actavis Pharma Recent Development
Table 130. Sivem Pharmaceuticals Corporation Information
Table 131. Sivem Pharmaceuticals Description and Business Overview
Table 132. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 133. Sivem Pharmaceuticals Bicalutamide Product
Table 134. Sivem Pharmaceuticals Recent Development
Table 135. Sorres Pharma Corporation Information
Table 136. Sorres Pharma Description and Business Overview
Table 137. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 138. Sorres Pharma Bicalutamide Product
Table 139. Sorres Pharma Recent Development
Table 140. Fresenius Kabi Corporation Information
Table 141. Fresenius Kabi Description and Business Overview
Table 142. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 143. Fresenius Kabi Bicalutamide Product
Table 144. Fresenius Kabi Recent Development
Table 145. ANI Pharmaceuticals Corporation Information
Table 146. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 147. ANI Pharmaceuticals Description and Business Overview
Table 148. ANI Pharmaceuticals Bicalutamide Product
Table 149. ANI Pharmaceuticals Recent Development
Table 150. Accel Pharma Corporation Information
Table 151. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 152. Accel Pharma Description and Business Overview
Table 153. Accel Pharma Bicalutamide Product
Table 154. Accel Pharma Recent Development
Table 155. Apotex Corporation Corporation Information
Table 156. Apotex Corporation Description and Business Overview
Table 157. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 158. Apotex Corporation Bicalutamide Product
Table 159. Apotex Corporation Recent Development
Table 160. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 161. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
Table 162. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 163. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product
Table 164. Shanghai Fudan Fuhua Pharmaceutical Recent Development
Table 165. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 166. Shanghai Zhaohui Pharmaceutical Description and Business Overview
Table 167. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 168. Shanghai Zhaohui Pharmaceutical Bicalutamide Product
Table 169. Shanghai Zhaohui Pharmaceutical Recent Development
Table 170. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 171. Zhejiang Haizheng Pharmaceutical Description and Business Overview
Table 172. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 173. Zhejiang Haizheng Pharmaceutical Bicalutamide Product
Table 174. Zhejiang Haizheng Pharmaceutical Recent Development
Table 175. Shanxi Zhendong Pharmaceutical Corporation Information
Table 176. Shanxi Zhendong Pharmaceutical Description and Business Overview
Table 177. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 178. Shanxi Zhendong Pharmaceutical Bicalutamide Product
Table 179. Shanxi Zhendong Pharmaceutical Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Bicalutamide Distributors List
Table 183. Bicalutamide Customers List
Table 184. Bicalutamide Market Trends
Table 185. Bicalutamide Market Drivers
Table 186. Bicalutamide Market Challenges
Table 187. Bicalutamide Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Bicalutamide Product Picture
Figure 2. Global Bicalutamide Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bicalutamide Sales Market Share by Application in 2021 & 2027
Figure 6. Single Drug For Prostate Cancer Examples
Figure 7. Combined Chemotherapy For Prostate Cancer Examples
Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer Examples
Figure 9. Global Bicalutamide Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bicalutamide Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Bicalutamide Sales (M Pcs) Growth Rate (2016-2027)
Figure 12. Global Bicalutamide Price Trends Growth Rate (2016-2027) (US$/Pcs)
Figure 13. Global Bicalutamide Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Bicalutamide Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Bicalutamide Sales (M Pcs) Growth Rate (2016-2027)
Figure 17. Europe Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Bicalutamide Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Bicalutamide Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Bicalutamide Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Bicalutamide Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Bicalutamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Bicalutamide Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Bicalutamide Players Market Share by Revenue in Bicalutamide: 2016 & 2020
Figure 28. Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Bicalutamide Revenue Share by Type (2016-2021)
Figure 30. Global Bicalutamide Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Bicalutamide Revenue Share by Application (2016-2021)
Figure 32. Global Bicalutamide Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Bicalutamide Sales Market Share by Type in 2020
Figure 34. North America Bicalutamide Sales Market Share by Application in 2020
Figure 35. Europe Bicalutamide Sales Market Share by Type in 2020
Figure 36. Europe Bicalutamide Sales Market Share by Application in 2020
Figure 37. China Bicalutamide Sales Market Share by Type in 2020
Figure 38. China Bicalutamide Sales Market Share by Application in 2020
Figure 39. Japan Bicalutamide Sales Market Share by Type in 2020
Figure 40. Japan Bicalutamide Sales Market Share by Application in 2020
Figure 41. Southeast Asia Bicalutamide Sales Market Share by Type in 2020
Figure 42. Southeast Asia Bicalutamide Sales Market Share by Application in 2020
Figure 43. India Bicalutamide Sales Market Share by Type in 2020
Figure 44. India Bicalutamide Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Bicalutamide
Figure 47. Manufacturing Process Analysis of Bicalutamide
Figure 48. Bicalutamide Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca CORDEN PHARMA GMBH Zeneca GmbH Actavis Pharma Sivem Pharmaceuticals Sorres Pharma Fresenius Kabi ANI Pharmaceuticals Accel Pharma Apotex Corporation Shanghai Fudan Fuhua Pharmaceutical Shanghai Zhaohui Pharmaceutical Zhejiang Haizheng Pharmaceutical Shanxi Zhendong Pharmaceutical